Overall, our results demostrate that telomerase plays a critical role in the pathogenesis of BCR-ABL-CML, and validate telomerase and the genes it regulates as targets for therapy in CML. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.